FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Bamia, A., Sinane, M., Naït-Saïdi, R., Dhiab, J., Keruzoré, M., Nguyen, P.H., Bertho, A., Soubigou, F., Halliez, S., Blondel, M., Trollet, C., Simonelig, M., Friocourt, G., Béringue, V., Bihel, F., Voisset, C. (2021). Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.  Neurotherapeutics 18(2): 1137--1150.
FlyBase ID
FBrf0251060
Publication Type
Research paper
Abstract
Prion diseases are caused by the propagation of PrPSc, the pathological conformation of the PrPC prion protein. The molecular mechanisms underlying PrPSc propagation are still unsolved and no therapeutic solution is currently available. We thus sought to identify new anti-prion molecules and found that flunarizine inhibited PrPSc propagation in cell culture and significantly prolonged survival of prion-infected mice. Using an in silico therapeutic repositioning approach based on similarities with flunarizine chemical structure, we tested azelastine, duloxetine, ebastine, loperamide and metixene and showed that they all have an anti-prion activity. Like flunarizine, these marketed drugs reduced PrPSc propagation in cell culture and in mouse cerebellum organotypic slice culture, and inhibited the protein folding activity of the ribosome (PFAR). Strikingly, some of these drugs were also able to alleviate phenotypes due to PABPN1 nuclear aggregation in cell and Drosophila models of oculopharyngeal muscular dystrophy (OPMD). These data emphasize the therapeutic potential of anti-PFAR drugs for neurodegenerative and neuromuscular proteinopathies.
PubMed ID
PubMed Central ID
PMC8423950 (PMC) (EuropePMC)
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    Neurotherapeutics
    Title
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
    ISBN/ISSN
    1933-7213 1878-7479
    Data From Reference
    Alleles (1)
    Genes (1)
    Human Disease Models (1)
    Transgenic Constructs (1)